menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Investigating the Impact of COVID-19 on Patients with Rheumatic Diseases

ACR 2021
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Which of our patients with rheumatic diseases are at higher risk for severe outcomes from COVID-19? That’s the exact question Dr. Jinoos Yazdany, Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital, addresses in her presentation at the 2021 American College of Rheumatology (ACR) Convergence.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Which of our patients with rheumatic diseases are at higher risk for severe outcomes from COVID-19? That’s the exact question Dr. Jinoos Yazdany, Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital, addresses in her presentation at the 2021 American College of Rheumatology (ACR) Convergence.

Facebook Comments

Schedule27 Nov 2021
Webpack App